Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for HYPD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 101.93M
March 31, 2026 58.50M
December 31, 2025 41.06M
September 30, 2025 70.76M
June 30, 2025 37.36M
March 31, 2025 -9.714M
December 31, 2024 -13.10M
September 30, 2024 3.719M
June 30, 2024 -2.370M
March 31, 2024 1.818M
December 31, 2023 8.999M
September 30, 2023 15.78M
June 30, 2023 10.52M
March 31, 2023 15.81M
December 31, 2022 17.23M
September 30, 2022 20.33M
June 30, 2022 23.61M
March 31, 2022 29.79M
December 31, 2021 20.47M
September 30, 2021 4.246M
Date Value
June 30, 2021 8.991M
March 31, 2021 12.14M
December 31, 2020 15.30M
September 30, 2020 18.65M
June 30, 2020 8.319M
March 31, 2020 12.33M
December 31, 2019 11.74M
September 30, 2019 16.40M
June 30, 2019 7.618M
March 31, 2019 12.46M
December 31, 2018 16.88M
September 30, 2018 19.74M
June 30, 2018 23.54M
March 31, 2018 26.86M
December 31, 2017 5.091M
September 30, 2017
June 30, 2017
March 31, 2017
December 31, 2016 3.009M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Omeros Corp. -51.35M
Talphera, Inc. 14.41M
ANI Pharmaceuticals, Inc. 597.21M
Corcept Therapeutics, Inc. 705.78M
Veru, Inc. 28.38M

Shareholders Equity (Quarterly) Related Metrics